Richard L. Mackman
Richard L. Mackman publishes mostly in Infectious Diseases, Molecular Biology and Epidemiology, on topics such as HIV/AIDS drug development and treatment, Respiratory viral infections research and SARS-CoV-2 and COVID-19 Research.
- World rank
- #587,860 of 7,710,434 ranked researchers
- Rank in United States
- #202,095 of 1,627,098
- Works
- 134
- Citations
- 9.7k
- Citations per work
- 72.3
What does Richard L. Mackman research?
Richard L. Mackman's work is mostly in Medicine (40%), Biochemistry, Genetics and Molecular Biology (19%), Chemistry (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences5440.4%
- Medicine5440.4%
- Everything else3929.3%
- Life Sciences3123.4%
- Physical Sciences96.9%
- Chemistry96.9%
- 1Infectious Diseases26% of their works
- 2Molecular Biology16% of their works
- 3Epidemiology14% of their works
- 4Organic Chemistry7% of their works
- 5Virology4% of their works
- 6Cancer Research3% of their works
Research topics
- HIV/AIDS drug development and treatment
- Respiratory viral infections research
- SARS-CoV-2 and COVID-19 Research
- Viral gastroenteritis research and epidemiology
- HIV Research and Treatment
- Biochemical and Molecular Research
- Protease and Inhibitor Mechanisms
- Pneumocystis jirovecii pneumonia detection and treatment
Which keywords describe Richard L. Mackman's research?
The keywords of their largest research topics: Vaccine, Antiretroviral Therapy, Epidemiology, Drug Resistance, HIV Infection, HIV, Human Metapneumovirus and Respiratory Syncytial Virus.
- Pneumonia
- Tissue Inhibitors of Metalloproteinases
- Nucleotide Metabolism
- Antibodies
- Rotavirus
- SARS-CoV-2
- Respiratory Syncytial Virus
- HIV
- Drug Resistance
- Antiretroviral Therapy
- Vaccine
- Epidemiology
- HIV Infection
- Human Metapneumovirus
- Coronavirus
- Norovirus
- AIDS
- Enzyme Regulation
- Matrix Metalloproteinases
- Pneumocystis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Vaccine503 topics
- Antiretroviral Therapy473 topics
- Epidemiology473 topics
- Drug Resistance251 topic
- HIV Infection251 topic
- HIV222 topics
- Human Metapneumovirus211 topic
- Respiratory Syncytial Virus211 topic
- Coronavirus201 topic
- SARS-CoV-2201 topic
- Norovirus171 topic
- Rotavirus171 topic
- AIDS131 topic
- Antibodies131 topic
- Enzyme Regulation121 topic
- Nucleotide Metabolism121 topic
- Matrix Metalloproteinases101 topic
- Tissue Inhibitors of Metalloproteinases101 topic
- Pneumocystis91 topic
- Pneumonia91 topic
Where does Richard L. Mackman work?
Richard L. Mackman's main affiliation in the publication record is Gilead Sciences (United States), United States.
How many publications and citations does Richard L. Mackman have?
OpenAlex counts 134 works and 9,687 citations for Richard L. Mackman, an h-index of 41, ranking #587,860 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Richard L. Mackman. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.